GSK Strengthens Vaccines Business with Acquisition of Okairos|
Friday, May 31, 2013
GSK to further expand its vaccines platform technology expertise through strategic acquisition.
Nottingham Further Invest In Green Chemistry Laboratory
Thursday, May 30, 2013
The School of Chemistry at the University of Nottingham (UK) has placed a sizeable order with Asynt to upgrade their undergraduate teaching facilities.
Valeant Pharmaceuticals to Acquire Bausch + Lomb For $8.7 Billion
Wednesday, May 29, 2013
Valeant will finance the transaction with debt and approximately $1.5 - $2.0 billion of new equity.
Drug Discovery of the Year Opens for Nominations
Monday, May 27, 2013
Judges welcome submissions from across the spectrum of pharmacology.
GSK Awarded Up to $200 Million by U.S. Government to Develop New Antibiotics
Friday, May 24, 2013
Funding will support development of drugs to fight antibiotic resistance and bioterrorism.
Prosonix Initiates Phase 2 Clinical Study with PSX1002 in COPD Patients
Thursday, May 23, 2013
First patients dosed with PSX1002, an orally inhaled, novel drug-only formulation of glycopyrronium bromide designed using Prosonix’ particle engineering platform.
Caligor Rx Managing Director Tammy Bishop Elected to Board of Directors for DA4S
Wednesday, May 22, 2013
Diversity Alliance for Science (DA4S) is a national organization that fosters supplier diversity within the life sciences industry.
Rhenovia Pharma Recognized as the World Leader in Biosimulation of CNS
Monday, May 20, 2013
In 2013, the company is preparing to gather a second round of EUR 2.5 million to accelerate its development.
BioDuro Opens State-of-the-Art Discovery Lab in Shanghai
Friday, May 17, 2013
New facility offers customized portfolio of services to meet expanding client demand.